The prevention and care of chronic diseases are among the priorities of the EU's current health strategy. Chronic Kidney Disease (CKD), one of the most common chronic degenerative diseases, is often accompanied by high mortality and morbidity, and it has a high socio-economic impact. On the other hand, with the incidence rate of 13,3 million cases per year, Acute Kidney Injury (AKI) is a major contributor to the global health burden and the global death toll of this disease is 1,7 million deaths yearly. Amidst the rising tide of AKI and CKD burden, the global nephrology workforce has failed to expand in order to meet the growing healthcare needs of this vulnerable patient population, thus cooperation at an international level would be necessary to boost workforce and sustainable models of healthcare delivery. The Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) will develop a European Strategic Partnership between Universities and clinic centres specialized in diagnostic and interventional nephrology with the overall objective (1) to stimulate the appeal in nephrology among learners at European level and (2) to improve the educational continuum, in order to respond to the unmet need to develop a policy framework for the provision of high-quality services within European health system.SPECIFIC OBJECTIVES developing innovative and multidisciplinary educational path with a patient-centered approach focusing on diagnostic and interventional nephrologyfostering the knowledge transfer from research to clinical practice in order to tackle risk management in health carestrengthening the cooperation among Universities and clinical centres in order to boost innovation and exchange of best practicespromoting the positive aspects of nephrology careers at European levelThe present proposal will jointly develop 4 curricula: Molecular Pathology, Vascular Access, Ultrasound and Peritoneal Dialysis.TARGET: 40 junior nephrologists (≤ 40 years old)

Europe still sees a quarter of the world's cancer cases each year, making cancer the second leading cause of death and illness in the region after cardiovascular diseases. Unless we take decisive action, lives lost to cancer in the EU are set to increase by more than 24% by 2035, making it the leading cause of death in the EU. Cross-border collaboration can address this challenge by combining data from various modalities and sources, extracting meaningful insights to deepen our understanding of cancer. However, ethical, legal, and national regulations, along with data access processes, including differing interpretations of the EU GDPR create significant hurdles. Technical interoperability issues across European cancer RIs, and patients' and citizens' rights to control who uses their personal information and for what purposes further complicate data sharing. The project will provide European researchers, SMEs, and innovators with a decentralized collaborative network, “UNCAN-CONNECT,” for cancer research. It consists of both technical components, a governance, compliance, and operational framework based on the UNCAN blueprint, with the goal of operationalizing it. The objective is to facilitate access to cancer data, promote open science, and revolutionize cancer research and treatment by co-creating an open-source federation of federations platform. It will be developed using specific use cases focused on six major cancer types: Paediatric, Lymphoid malignancies, Pancreatic cancer, Ovarian, Lung, and Prostate cancers and active collaboration with a diverse range of stakeholders, including researchers, SMEs, industrial end users, and citizens. It will build on existing European RIs such as BBMRI as well as initiatives like EOSC4CANCER, CanSERV, EUCAIM, to enable seamless storage, access, sharing, and processing of data across Member States and associated countries. This approach will foster interoperability and collaboration, accelerating progress in cancer research. This action is part of the Cancer Mission clusters of projects 'Understanding' established in 2022.

Public Procurement Organizations (PPO) are rethinking existing practices as currently, quality of care is compromised and they do not lead to economic most advantageous purchasing. PPO involved in different PPI/PCP are teaming up around a novel approach of Value Based Procurement (VBP) joined by national/regional procurement organizations and service providers with a common vision, a value based procurement of innovative solutions to enable the needed transformation of health and social care delivery. The EURIPHI consortium involves 14 PPO, 10 with a regional or national remit and service providers from 6 countries who together, procure for more than 200 care service providers. The European Health Public Procurement Alliance members are also contributing to the project. This provides a strong basis to build out a Value Based PPI Community of Practice (CoP) to successfully achieve one of the key objectives of the CSA. The EURIPHI common vision is to build out around a MEAT VBP framework which will be made accessible with adaptions necessary to support the cross-border PPI leading to “MEAT Value Based PPI”. Cross-border PPI-Legal guidance will be developed by legal expert partners. Innovative solutions will be identified in the fields of rapid diagnostic (RD) tools in infectious disease and in the most promising integrated care services (IC). The identification of specific demands and prioritization will be done by expert partners and through the establishment of the Health Regional Network including stakeholders. Following an open market consultation, case testing will be performed for 1-2 RD and 3-4 IC innovative solutions and serve as an input for the PPI or PCP writing of SC1-BHC-20-2020. Dissemination and exploitation will be done by partners with a European or International remit and by an involvement of all partners in a blog series and EURIPHI Insights, with the support of a permanent secretariat.